Matribhumi Samachar English
– Regulatory alignment with FDA confirmed, clearing path to pivotal U.S. clinical trial – – 150-page strategic business plan and advanced financial models completed – – Investor outreach launched to fund clinical execution and market entry – Vancouver, British Columbia and Sacramento, California–(Newsfile Corp. – May 16, 2025) – Izotropic …
Read More »Izotropic to Present at Investor Conference March 13th
– CEO to discuss IzoView’s competitive advantage, expansion strategy, and potential revenue models – – Event includes live Q and A, attendance is complimentary – – Individual and institutional investors, advisors, and analysts welcome – Vancouver, British Columbia and Sacramento, California–(Newsfile Corp. – March 10, 2025) – Izotropic Corporation (CSE: …
Read More »Izotropic to Present at Investor Conference February 6th
– CEO to present overview of Company value proposition, unique catalysts, and near-term objectives – – Event includes live Q and A, attendance is complimentary – – Individual and institutional investors, advisors, and analysts welcome – Vancouver, British Columbia and Sacramento, California–(Newsfile Corp. – February 3, 2025) – Izotropic Corporation …
Read More »Izotropic Announces Timelines and Milestones to IzoView Product Launch
– Unique dense breast tissue focus to drive expedited recruitment rates; modular clinical study design reduces time to PMA submission by ~6 months – – 3 Site U.S.-based clinical study enables early data collection to kickstart European CE Mark Application – – Company to announce development of 2 new medical …
Read More »